Explore Innocore’s capabilities across drug delivery development, pharmaceutical formulation, analytical and process development, technology transfer and manufacturing support.
Our work focuses on complex formulations, including polymer-based sustained-release systems for peptides and biologics. The appropriate development and manufacturing approach depends on the API, dosage form and requirements of each program.
01 / DRUG DELIVERY & FORMULATION
Formulation development considers the properties of the API, the delivery system and the intended product characteristics. Explore the capabilities involved in investigating complex sustained-release formulations.
01 / DEVELOPMENT
Development considerations for injectable formulations designed to release an API over an extended period, including polymer-based delivery systems and formulation characterization.
02 / DEVELOPMENT
Investigation of drug delivery technologies, API compatibility and formulation characteristics relevant to controlled and sustained-release applications.
03 / DEVELOPMENT
Evaluation of candidate formulations, including API stability, drug loading, polymer compatibility and relevant dosage form characteristics.
02 / PROCESS & ANALYTICAL DEVELOPMENT
Manufacturing processes and analytical methods must be evaluated in relation to the formulation and its quality attributes. These capabilities support process understanding, characterization and preparation for subsequent manufacturing activities.
04 / PROCESS
Investigation of manufacturing parameters, reproducibility and scalability, with attention to the effects of processing conditions on formulation quality.
05 / ANALYTICAL
Development of analytical approaches for API characterization, molecular integrity, drug content, physical attributes and in vitro release testing.
06 / TRANSFER
Structured transfer of formulation, process and analytical knowledge to support implementation in a receiving manufacturing environment.
03 / MANUFACTURING & CDMO SUPPORT
Manufacturing requirements depend on the intended use of the material, development stage and applicable quality framework. Explore Innocore’s capabilities and considerations across nonclinical development, GMP manufacturing and integrated CDMO services.
07 / NONCLINICAL
Manufacturing considerations for nonclinical test materials, including formulation consistency, product characterization, traceability and documentation requirements.
08 / MANUFACTURING
Manufacturing considerations for complex injectable formulations, including process controls, analytical requirements and pharmaceutical quality oversight.
09 / INTEGRATED SERVICES
Integrated development and manufacturing support connecting drug delivery, formulation, analytical development, process development and technology transfer.
Every development program introduces its own technical considerations. Contact Innocore to discuss your API, formulation technology, development stage and the capabilities relevant to your project.
Contact Innocore